Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Generic Medicine market report explains the definition, types, applications, major countries, and major players of the Generic Medicine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Dr Reddy's
Aurobindo
Hikma
Stada Arzneimittel
Aspen
Sun Pharmaceutical
Krka Group
Zydus Cadila
Valeant
Pfizer (Hospira)
Novartis - Sandoz
Apotex
Cipla
Lupin
Mylan
Teva
Sanofi
ENDO (Par Pharmaceutical)
Nichi-Iko Pharmaceutical
Fresenius Kabi
By Type:
Simple Generic Drugs
Super Generic Drugs
Biosimilars
By Application:
CNS
Cardiovascular
Respiratory
Rheumatology
Diabetes
Oncology
By End-User:
CNS
Cardiovascular
Respiratory
Rheumatology
Diabetes
Oncology
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Generic Medicine Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Generic Medicine Outlook to 2028- Original Forecasts
-
2.2 Generic Medicine Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Generic Medicine Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Generic Medicine Market- Recent Developments
-
6.1 Generic Medicine Market News and Developments
-
6.2 Generic Medicine Market Deals Landscape
7 Generic Medicine Raw Materials and Cost Structure Analysis
-
7.1 Generic Medicine Key Raw Materials
-
7.2 Generic Medicine Price Trend of Key Raw Materials
-
7.3 Generic Medicine Key Suppliers of Raw Materials
-
7.4 Generic Medicine Market Concentration Rate of Raw Materials
-
7.5 Generic Medicine Cost Structure Analysis
-
7.5.1 Generic Medicine Raw Materials Analysis
-
7.5.2 Generic Medicine Labor Cost Analysis
-
7.5.3 Generic Medicine Manufacturing Expenses Analysis
8 Global Generic Medicine Import and Export Analysis (Top 10 Countries)
-
8.1 Global Generic Medicine Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Generic Medicine Export by Region (Top 10 Countries) (2017-2028)
9 Global Generic Medicine Market Outlook by Types and Applications to 2022
-
9.1 Global Generic Medicine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Simple Generic Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Super Generic Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Biosimilars Consumption and Growth Rate (2017-2022)
-
9.1.4 Global By Application: Consumption and Growth Rate (2017-2022)
-
9.1.5 Global CNS Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Cardiovascular Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Respiratory Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Rheumatology Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.1.10 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2 Global Generic Medicine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global CNS Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiovascular Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Respiratory Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Rheumatology Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Generic Medicine Market Analysis and Outlook till 2022
-
10.1 Global Generic Medicine Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Generic Medicine Consumption (2017-2022)
-
10.2.2 Canada Generic Medicine Consumption (2017-2022)
-
10.2.3 Mexico Generic Medicine Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Generic Medicine Consumption (2017-2022)
-
10.3.2 UK Generic Medicine Consumption (2017-2022)
-
10.3.3 Spain Generic Medicine Consumption (2017-2022)
-
10.3.4 Belgium Generic Medicine Consumption (2017-2022)
-
10.3.5 France Generic Medicine Consumption (2017-2022)
-
10.3.6 Italy Generic Medicine Consumption (2017-2022)
-
10.3.7 Denmark Generic Medicine Consumption (2017-2022)
-
10.3.8 Finland Generic Medicine Consumption (2017-2022)
-
10.3.9 Norway Generic Medicine Consumption (2017-2022)
-
10.3.10 Sweden Generic Medicine Consumption (2017-2022)
-
10.3.11 Poland Generic Medicine Consumption (2017-2022)
-
10.3.12 Russia Generic Medicine Consumption (2017-2022)
-
10.3.13 Turkey Generic Medicine Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Generic Medicine Consumption (2017-2022)
-
10.4.2 Japan Generic Medicine Consumption (2017-2022)
-
10.4.3 India Generic Medicine Consumption (2017-2022)
-
10.4.4 South Korea Generic Medicine Consumption (2017-2022)
-
10.4.5 Pakistan Generic Medicine Consumption (2017-2022)
-
10.4.6 Bangladesh Generic Medicine Consumption (2017-2022)
-
10.4.7 Indonesia Generic Medicine Consumption (2017-2022)
-
10.4.8 Thailand Generic Medicine Consumption (2017-2022)
-
10.4.9 Singapore Generic Medicine Consumption (2017-2022)
-
10.4.10 Malaysia Generic Medicine Consumption (2017-2022)
-
10.4.11 Philippines Generic Medicine Consumption (2017-2022)
-
10.4.12 Vietnam Generic Medicine Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Generic Medicine Consumption (2017-2022)
-
10.5.2 Colombia Generic Medicine Consumption (2017-2022)
-
10.5.3 Chile Generic Medicine Consumption (2017-2022)
-
10.5.4 Argentina Generic Medicine Consumption (2017-2022)
-
10.5.5 Venezuela Generic Medicine Consumption (2017-2022)
-
10.5.6 Peru Generic Medicine Consumption (2017-2022)
-
10.5.7 Puerto Rico Generic Medicine Consumption (2017-2022)
-
10.5.8 Ecuador Generic Medicine Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Generic Medicine Consumption (2017-2022)
-
10.6.2 Kuwait Generic Medicine Consumption (2017-2022)
-
10.6.3 Oman Generic Medicine Consumption (2017-2022)
-
10.6.4 Qatar Generic Medicine Consumption (2017-2022)
-
10.6.5 Saudi Arabia Generic Medicine Consumption (2017-2022)
-
10.6.6 United Arab Emirates Generic Medicine Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Generic Medicine Consumption (2017-2022)
-
10.7.2 South Africa Generic Medicine Consumption (2017-2022)
-
10.7.3 Egypt Generic Medicine Consumption (2017-2022)
-
10.7.4 Algeria Generic Medicine Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Generic Medicine Consumption (2017-2022)
-
10.8.2 New Zealand Generic Medicine Consumption (2017-2022)
11 Global Generic Medicine Competitive Analysis
-
11.1 Dr Reddy's
-
11.1.1 Dr Reddy's Company Details
-
11.1.2 Dr Reddy's Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Dr Reddy's Generic Medicine Main Business and Markets Served
-
11.1.4 Dr Reddy's Generic Medicine Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Aurobindo
-
11.2.1 Aurobindo Company Details
-
11.2.2 Aurobindo Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Aurobindo Generic Medicine Main Business and Markets Served
-
11.2.4 Aurobindo Generic Medicine Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Hikma
-
11.3.1 Hikma Company Details
-
11.3.2 Hikma Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Hikma Generic Medicine Main Business and Markets Served
-
11.3.4 Hikma Generic Medicine Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Stada Arzneimittel
-
11.4.1 Stada Arzneimittel Company Details
-
11.4.2 Stada Arzneimittel Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Stada Arzneimittel Generic Medicine Main Business and Markets Served
-
11.4.4 Stada Arzneimittel Generic Medicine Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Aspen
-
11.5.1 Aspen Company Details
-
11.5.2 Aspen Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Aspen Generic Medicine Main Business and Markets Served
-
11.5.4 Aspen Generic Medicine Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Sun Pharmaceutical
-
11.6.1 Sun Pharmaceutical Company Details
-
11.6.2 Sun Pharmaceutical Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Sun Pharmaceutical Generic Medicine Main Business and Markets Served
-
11.6.4 Sun Pharmaceutical Generic Medicine Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Krka Group
-
11.7.1 Krka Group Company Details
-
11.7.2 Krka Group Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Krka Group Generic Medicine Main Business and Markets Served
-
11.7.4 Krka Group Generic Medicine Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Zydus Cadila
-
11.8.1 Zydus Cadila Company Details
-
11.8.2 Zydus Cadila Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Zydus Cadila Generic Medicine Main Business and Markets Served
-
11.8.4 Zydus Cadila Generic Medicine Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Valeant
-
11.9.1 Valeant Company Details
-
11.9.2 Valeant Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Valeant Generic Medicine Main Business and Markets Served
-
11.9.4 Valeant Generic Medicine Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Pfizer (Hospira)
-
11.10.1 Pfizer (Hospira) Company Details
-
11.10.2 Pfizer (Hospira) Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Pfizer (Hospira) Generic Medicine Main Business and Markets Served
-
11.10.4 Pfizer (Hospira) Generic Medicine Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Novartis - Sandoz
-
11.11.1 Novartis - Sandoz Company Details
-
11.11.2 Novartis - Sandoz Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Novartis - Sandoz Generic Medicine Main Business and Markets Served
-
11.11.4 Novartis - Sandoz Generic Medicine Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Apotex
-
11.12.1 Apotex Company Details
-
11.12.2 Apotex Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Apotex Generic Medicine Main Business and Markets Served
-
11.12.4 Apotex Generic Medicine Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Cipla
-
11.13.1 Cipla Company Details
-
11.13.2 Cipla Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Cipla Generic Medicine Main Business and Markets Served
-
11.13.4 Cipla Generic Medicine Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Lupin
-
11.14.1 Lupin Company Details
-
11.14.2 Lupin Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Lupin Generic Medicine Main Business and Markets Served
-
11.14.4 Lupin Generic Medicine Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Mylan
-
11.15.1 Mylan Company Details
-
11.15.2 Mylan Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Mylan Generic Medicine Main Business and Markets Served
-
11.15.4 Mylan Generic Medicine Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Teva
-
11.16.1 Teva Company Details
-
11.16.2 Teva Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Teva Generic Medicine Main Business and Markets Served
-
11.16.4 Teva Generic Medicine Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Sanofi
-
11.17.1 Sanofi Company Details
-
11.17.2 Sanofi Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Sanofi Generic Medicine Main Business and Markets Served
-
11.17.4 Sanofi Generic Medicine Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 ENDO (Par Pharmaceutical)
-
11.18.1 ENDO (Par Pharmaceutical) Company Details
-
11.18.2 ENDO (Par Pharmaceutical) Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 ENDO (Par Pharmaceutical) Generic Medicine Main Business and Markets Served
-
11.18.4 ENDO (Par Pharmaceutical) Generic Medicine Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Nichi-Iko Pharmaceutical
-
11.19.1 Nichi-Iko Pharmaceutical Company Details
-
11.19.2 Nichi-Iko Pharmaceutical Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Nichi-Iko Pharmaceutical Generic Medicine Main Business and Markets Served
-
11.19.4 Nichi-Iko Pharmaceutical Generic Medicine Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Fresenius Kabi
-
11.20.1 Fresenius Kabi Company Details
-
11.20.2 Fresenius Kabi Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Fresenius Kabi Generic Medicine Main Business and Markets Served
-
11.20.4 Fresenius Kabi Generic Medicine Product Portfolio
-
11.20.5 Recent Research and Development Strategies
12 Global Generic Medicine Market Outlook by Types and Applications to 2028
-
12.1 Global Generic Medicine Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Simple Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Super Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global By Application: Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global CNS Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)
-
12.1.7 Global Respiratory Consumption Forecast and Growth Rate (2022-2028)
-
12.1.8 Global Rheumatology Consumption Forecast and Growth Rate (2022-2028)
-
12.1.9 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
12.1.10 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Generic Medicine Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global CNS Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Respiratory Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Rheumatology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Generic Medicine Market Analysis and Outlook to 2028
-
13.1 Global Generic Medicine Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Generic Medicine Consumption Forecast (2022-2028)
-
13.2.2 Canada Generic Medicine Consumption Forecast (2022-2028)
-
13.2.3 Mexico Generic Medicine Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Generic Medicine Consumption Forecast (2022-2028)
-
13.3.2 UK Generic Medicine Consumption Forecast (2022-2028)
-
13.3.3 Spain Generic Medicine Consumption Forecast (2022-2028)
-
13.3.4 Belgium Generic Medicine Consumption Forecast (2022-2028)
-
13.3.5 France Generic Medicine Consumption Forecast (2022-2028)
-
13.3.6 Italy Generic Medicine Consumption Forecast (2022-2028)
-
13.3.7 Denmark Generic Medicine Consumption Forecast (2022-2028)
-
13.3.8 Finland Generic Medicine Consumption Forecast (2022-2028)
-
13.3.9 Norway Generic Medicine Consumption Forecast (2022-2028)
-
13.3.10 Sweden Generic Medicine Consumption Forecast (2022-2028)
-
13.3.11 Poland Generic Medicine Consumption Forecast (2022-2028)
-
13.3.12 Russia Generic Medicine Consumption Forecast (2022-2028)
-
13.3.13 Turkey Generic Medicine Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Generic Medicine Consumption Forecast (2022-2028)
-
13.4.2 Japan Generic Medicine Consumption Forecast (2022-2028)
-
13.4.3 India Generic Medicine Consumption Forecast (2022-2028)
-
13.4.4 South Korea Generic Medicine Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Generic Medicine Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Generic Medicine Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Generic Medicine Consumption Forecast (2022-2028)
-
13.4.8 Thailand Generic Medicine Consumption Forecast (2022-2028)
-
13.4.9 Singapore Generic Medicine Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Generic Medicine Consumption Forecast (2022-2028)
-
13.4.11 Philippines Generic Medicine Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Generic Medicine Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Generic Medicine Consumption Forecast (2022-2028)
-
13.5.2 Colombia Generic Medicine Consumption Forecast (2022-2028)
-
13.5.3 Chile Generic Medicine Consumption Forecast (2022-2028)
-
13.5.4 Argentina Generic Medicine Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Generic Medicine Consumption Forecast (2022-2028)
-
13.5.6 Peru Generic Medicine Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Generic Medicine Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Generic Medicine Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Generic Medicine Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Generic Medicine Consumption Forecast (2022-2028)
-
13.6.3 Oman Generic Medicine Consumption Forecast (2022-2028)
-
13.6.4 Qatar Generic Medicine Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Generic Medicine Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Generic Medicine Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Generic Medicine Consumption Forecast (2022-2028)
-
13.7.2 South Africa Generic Medicine Consumption Forecast (2022-2028)
-
13.7.3 Egypt Generic Medicine Consumption Forecast (2022-2028)
-
13.7.4 Algeria Generic Medicine Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Generic Medicine Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Generic Medicine Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Generic Medicine
-
Figure of Generic Medicine Picture
-
Table Global Generic Medicine Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Generic Medicine Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Simple Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Super Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Global By Application: Consumption and Growth Rate (2017-2022)
-
Figure Global CNS Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatology Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global CNS Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatology Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Generic Medicine Consumption by Country (2017-2022)
-
Table North America Generic Medicine Consumption by Country (2017-2022)
-
Figure United States Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Canada Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Mexico Generic Medicine Consumption and Growth Rate (2017-2022)
-
Table Europe Generic Medicine Consumption by Country (2017-2022)
-
Figure Germany Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure UK Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Spain Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Belgium Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure France Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Italy Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Denmark Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Finland Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Norway Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Sweden Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Poland Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Russia Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Turkey Generic Medicine Consumption and Growth Rate (2017-2022)
-
Table APAC Generic Medicine Consumption by Country (2017-2022)
-
Figure China Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Japan Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure India Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Thailand Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Singapore Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Philippines Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Generic Medicine Consumption and Growth Rate (2017-2022)
-
Table South America Generic Medicine Consumption by Country (2017-2022)
-
Figure Brazil Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Colombia Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Chile Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Argentina Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Peru Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Generic Medicine Consumption and Growth Rate (2017-2022)
-
Table GCC Generic Medicine Consumption by Country (2017-2022)
-
Figure Bahrain Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Oman Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Qatar Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Generic Medicine Consumption and Growth Rate (2017-2022)
-
Table Africa Generic Medicine Consumption by Country (2017-2022)
-
Figure Nigeria Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure South Africa Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Egypt Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure Algeria Generic Medicine Consumption and Growth Rate (2017-2022)
-
Table Oceania Generic Medicine Consumption by Country (2017-2022)
-
Figure Australia Generic Medicine Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Generic Medicine Consumption and Growth Rate (2017-2022)
-
Table Dr Reddy's Company Details
-
Table Dr Reddy's Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy's Generic Medicine Main Business and Markets Served
-
Table Dr Reddy's Generic Medicine Product Portfolio
-
Table Aurobindo Company Details
-
Table Aurobindo Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo Generic Medicine Main Business and Markets Served
-
Table Aurobindo Generic Medicine Product Portfolio
-
Table Hikma Company Details
-
Table Hikma Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hikma Generic Medicine Main Business and Markets Served
-
Table Hikma Generic Medicine Product Portfolio
-
Table Stada Arzneimittel Company Details
-
Table Stada Arzneimittel Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Stada Arzneimittel Generic Medicine Main Business and Markets Served
-
Table Stada Arzneimittel Generic Medicine Product Portfolio
-
Table Aspen Company Details
-
Table Aspen Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aspen Generic Medicine Main Business and Markets Served
-
Table Aspen Generic Medicine Product Portfolio
-
Table Sun Pharmaceutical Company Details
-
Table Sun Pharmaceutical Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Generic Medicine Main Business and Markets Served
-
Table Sun Pharmaceutical Generic Medicine Product Portfolio
-
Table Krka Group Company Details
-
Table Krka Group Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Krka Group Generic Medicine Main Business and Markets Served
-
Table Krka Group Generic Medicine Product Portfolio
-
Table Zydus Cadila Company Details
-
Table Zydus Cadila Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zydus Cadila Generic Medicine Main Business and Markets Served
-
Table Zydus Cadila Generic Medicine Product Portfolio
-
Table Valeant Company Details
-
Table Valeant Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Generic Medicine Main Business and Markets Served
-
Table Valeant Generic Medicine Product Portfolio
-
Table Pfizer (Hospira) Company Details
-
Table Pfizer (Hospira) Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer (Hospira) Generic Medicine Main Business and Markets Served
-
Table Pfizer (Hospira) Generic Medicine Product Portfolio
-
Table Novartis - Sandoz Company Details
-
Table Novartis - Sandoz Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis - Sandoz Generic Medicine Main Business and Markets Served
-
Table Novartis - Sandoz Generic Medicine Product Portfolio
-
Table Apotex Company Details
-
Table Apotex Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apotex Generic Medicine Main Business and Markets Served
-
Table Apotex Generic Medicine Product Portfolio
-
Table Cipla Company Details
-
Table Cipla Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Generic Medicine Main Business and Markets Served
-
Table Cipla Generic Medicine Product Portfolio
-
Table Lupin Company Details
-
Table Lupin Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Generic Medicine Main Business and Markets Served
-
Table Lupin Generic Medicine Product Portfolio
-
Table Mylan Company Details
-
Table Mylan Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Generic Medicine Main Business and Markets Served
-
Table Mylan Generic Medicine Product Portfolio
-
Table Teva Company Details
-
Table Teva Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Generic Medicine Main Business and Markets Served
-
Table Teva Generic Medicine Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Generic Medicine Main Business and Markets Served
-
Table Sanofi Generic Medicine Product Portfolio
-
Table ENDO (Par Pharmaceutical) Company Details
-
Table ENDO (Par Pharmaceutical) Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table ENDO (Par Pharmaceutical) Generic Medicine Main Business and Markets Served
-
Table ENDO (Par Pharmaceutical) Generic Medicine Product Portfolio
-
Table Nichi-Iko Pharmaceutical Company Details
-
Table Nichi-Iko Pharmaceutical Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nichi-Iko Pharmaceutical Generic Medicine Main Business and Markets Served
-
Table Nichi-Iko Pharmaceutical Generic Medicine Product Portfolio
-
Table Fresenius Kabi Company Details
-
Table Fresenius Kabi Generic Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fresenius Kabi Generic Medicine Main Business and Markets Served
-
Table Fresenius Kabi Generic Medicine Product Portfolio
-
Figure Global Simple Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Super Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global By Application: Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CNS Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CNS Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Generic Medicine Consumption Forecast by Country (2022-2028)
-
Table North America Generic Medicine Consumption Forecast by Country (2022-2028)
-
Figure United States Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Generic Medicine Consumption Forecast by Country (2022-2028)
-
Figure Germany Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Generic Medicine Consumption Forecast by Country (2022-2028)
-
Figure China Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Generic Medicine Consumption Forecast by Country (2022-2028)
-
Figure Brazil Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Generic Medicine Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Generic Medicine Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Generic Medicine Consumption Forecast by Country (2022-2028)
-
Figure Australia Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Generic Medicine Consumption Forecast and Growth Rate (2022-2028)
-
